Abstract
Recent experimental work has shown that the N501Y mutation in the SARS-CoV-2 S glycoprotein’s receptor binding domain (RBD) increases binding affinity to the angiotensin-converting enzyme 2 (ACE2), primarily by overcompensating for a less favorable enthalpy of binding by greatly reducing the entropic penalty for complex formation, but the basis for this entropic overcompensation is not clear [Prévost et al., J. Biol. Chem. (2021) 297;101151]. We use all-atom molecular dynamics simulations and free-energy calculations to qualitatively assess the impact of the N501Y mutation on enthalpy and entropy of binding of RBD to ACE2. Our calculations correctly predict that N501Y causes a less favorable enthalpy of binding to ACE2 relative to the original strain. Further, we show that this is overcompensated for by a more entropically favorable increase in large-scale quaternary flexibility and intra-protein root-mean squared fluctuations of residue positions upon binding in both RBD and ACE2. The enhanced quaternary flexibility stems from N501Y’s ability to remodel the interresidue interactions between the two proteins away from interactions central to the epitope and toward more peripheral interactions. These findings suggest that an important factor in determining protein-protein binding affinity is the degree to which fluctuations are distributed throughout the complex, and that residue mutations that may seem to result in weaker interactions than their wild-type counterparts may yet result increased binding affinity thanks to their ability to suppress unfavorable entropy changes upon binding.
Graphical Abstract

Introduction
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a novel virus that leads to the infectious disease Coronavirus 2019 (COVID-19). Initial transmission of SARS-CoV-2 involves binding of the S glycoprotein to sACE2 receptors on target cells.1 SARS-CoV-2 S is a class-I trimeric viral fusion protein with each protomer comprising an S1 and S2 subunit (Fig. 1).2 S2 anchors S into the viral membrane and S1 is exposed on the membrane surface. The receptor binding domain (RBD) of S1 sub-unit binds to the ACE2 receptor on host cells. The ACE2 recognition epitope of RBD is hidden in the native timeric conformation, which much transition into an “RBD-up” conformation to allow sRBD:sACE2 complexation. This initial binding is the first step in membrane fusion and the energetically downhill cascade of events that lead to host cell entry.3 RBD is the locus of several point mutations that have led to the rise of many new SARS-CoV-2 variants.
Figure 1:

(A) SARS-CoV-2 S Glycoprotein S trimer with ACE2 (green) bound to one sRBD (orange) in the up position. (B) sACE2 bound to sRBD as modeled in this work (from PDB 6m0j4).
One such point mutation is the change from asparagine to tyrosine at position 501 (N501Y). X-ray crystallographic structures shows that 501 interacts directly with residues on ACE2.4 N501Y is present in many variants, including Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), and Omicron (B.1.1.529).5,6 The N501Y mutation has been shown to increase sACE2-sRBD binding affinity7,8 as well as infectiousness and transmissibility of SARS-CoV-2.9,10 Using isothermal titration calorimetry on soluble versions of RBD and ACE2, Prévost et al. showed that N501YsRBD leads to less favorable enthalpy of binding which is more than offset by more favorable entropy of binding, which both increases the overall sRBD:sACE2 binding affinity and suppresses the decrease in binding affinity with an increase in temperature, all relative to the Wuhan strain. This evidently represents an example of “entropic overcompensation”, where a mutation results in increased binding affinity because of a large favorable decrease in entropy of binding that more than offsets an increase in the enthalpy of binding. The basis for this entropic overcompensation is not clear. The competing roles of enthalpy and entropy changes upon binding to binding affinity are well-appreciated, but attribution of such remarkably large changes to both to one residue in a protein protein interface can be challenging.11 To attempt an explanation, we have conducted a series of all-atom molecular dynamics (MD) simulations of the soluble form of RBD (sRBD), the soluble form of ACE2 (sACE2), and their complexes. We evaluate the enthalpy of binding for both the Wuhan and N501Y strains, as well as the impact of binding on the conformational flexibility of the complex and of each protein. Our results allow us to postulate a structural rationale for the N501Y mutation’s effect on both the enthalpy and entropy of binding consistent with experimental results.
Methods
For this work we modeled five distinct systems: sRBD, sRBDN501Y, sACE2, sRBD:sACE2, and sRBDN501Y:sACE2. For purposes of distigushing between systems, we will refer to those systems in which the sRBD sequence is that of the Wuhan strain as “wild-type” and those with the N501YsRBD mutation as “mutant”. All atomic coordinates were based on the PDB entry 6M0J.4 All systems were solvated in explicit TIP3P water and neutralized with counterions. Equilibrium MD simulations were run using NAMD for 40 ns.12 Three replicas of each system were simulated. All systems utilized periodic boundary conditions, a nonbonded cutoff of 11 Å, a particle-mesh Ewald grid spacing of 1 Å, and a timestep of 2 fs. All simulations were conducted at 310 K using a Langevin themostat with a friction parameter of 5 ps−1.
Molecular-Mechanics/Generalized Born Surface Area (MM/GBSA) free-energy calculations were conducted using VMD13 to evaluate the enthalpic contribution to binding free energy.14–16 This follows examples set by several recent works in which MM/GBSA proved useful in estimating protein-protein binding free energy.17–28 In particular, MM/GBSA and related methods have been used to study the effects of mutations on the complex between the SARS-Cov-2 S RDB and the ACE2 ectodomain.23–28 We consider here the same PDB structure (6m0j4) as a basis to use the same method estimate the enthalpic contribution to binding free energy between SARS-CoV-2 S RBD and ACE2.
Entropic contributions were estimated using carma.29 Heavy atoms in residues at the sRBD:sACE2 interface were selected to fit corresponding trajectories in both the WT and N501YsRBD mutation and an approximation of the upper limit to the absolute entropy was calculated using Schlitter’s formula.30
Total hydrogen bond occupancy and interatomic distances were evaluated using VMD.13 To identify hydrogen bonds, a distance-based method was used where we identify two residues H-bonded when the distance between their heavy atoms is ≤3.3 Å over 30 ns of equilibrated MD trajectory per replica. All heavy atoms at the interface of each system was assessed with the respective nearest neighbor distance atomic distance for the partner residue. Normal mode analysis was conducted using Bio3d31 and visualized in Pymol.32
Results and Discussion
Binding thermodynamics
We first demonstrate that our simulations provide a qualitatively correct comparison of the thermodynamics of sRBD:sACE2 binding between WT and N501Y systems. In Table 1, we report the enthalpic contribution computed using MM/GBSA, denoted ΔHMM/GBSA, and the entropic contribution to the free energy of binding calculated via Schlitter’s formula over sRBD:sACE2 interface heavy atoms, denoted −TΔSs, both in kcal/mol, for both the WT and mutant sRBDs. Consistent with the experimental findings of Prévost et al.,7 reported for reference in Table 1, we see that the effect of the N501YsRBD mutation is to make the enthalpy of binding less favorable while making the entropy of binding more favorable. We stress that we are not claiming that the Schlitter-based entropy change over interface residues constitutes the total entropic contribution to binding; only that it suggests that entropic contributions from the residues at the interface are consistent with the experimental observation that −TΔS is lower for N501YsRBD than for WT. The Schlitter entropy includes contact residues from both sRBD and sACE2. With this correspondence between simulations and experiments establish, we next explain the bases for these thermodynamic differences.
Table 1:
MM/GBSA enthalpy of binding (ΔHMM/GBSA) and Schlitter’s entropy of binding among interface residues (−TΔSs) WT and N501YsRBD systems at 310 K, computed from MD simulations. For reference, enthalpies and entropies from isothermal titration calorimetry experiments at 310 K of Prévost et al.7 are shown (ΔH and −TΔS, respectively).
| This work (simulations) | ITC7 | |||
|---|---|---|---|---|
| System | ΔHMM/GBSA (kcal/mol) | −TΔSs (kcal/mol) | ΔH (kcal/mol) | −TΔS (kcal/mol) |
| WT | −30.22 ± 3.54 | 22.03 ± 7.39 | −22.9 | 12.4 |
| N501Y | −27.63 ± 1.29 | 18.11 ± 5.49 | −21.6 | 10.0 |
Enthalpic effects of the N501Y mutation
We characterized enthalpic contributions to binding by enumerating and classifying residue-residue interactions at the protein-protein interface as depicted in Fig. 2. For all residue pairs at the interface, distributions of nearest interatomic distance in each pair were calculated. A instantaneous residue-residue contact is defined as any pair of residues for which at least one atom on the first is within 6 Å of at least one atom on the second. Although we focus on the interface, we tabulated interactions both across the RBD:ACE2 interface and within either RBD or ACE2. Fig. 3 depicts the most significant interresidue interactions at the interface, defined as those residue pairs which showed the largest change in nearest interatomic distance between the WT and mutant systems. This figure also serves to illustrate the extended nature of the interface which prompts us to classify the interactions between “peripheral” and “central”. We now turn to detailed consideration of each set of residue pairs.
Figure 2:

Section of the sRBD:sACE2 interface that is evaluated for residue contacts. N501 is shown in red. Peripheral interactions are outlined in purple while central interactions are outlined in yellow.
Figure 3:

Detailed views of the sRBD:sACE2 interface in representative configurations from the MD simulations; (A) WT, (B) N501Y. In both panels, residue 501sRBD is shown in red licorice, and sRBD in red cartoon and sACE2 in green cartoon.
We present close-up 3D depictions of several important sets of enthalpically important residue-residue contacts bridging the interface in the Supplement. Fig. S1 shows the interactions that K353sACE2 makes with residues in sRBD in both the WT and mutant systems. Fig. S1(A) and (C) show how K353sACE2 switches from H-bonding to the backbone carbonyl of G496sRBD in WT to H-bonding to the side-chain hydroxyl of Y501sRBD in the mutant. Both of these H-bonds are fairly well occupied, as evidenced by the interatomic density distributions compiled from the final 30 ns of all MD simulations, shown in Fig. S1(B) and (D). We note that this switch of interaction partners of K353sACE2 moves an RDB:ACE2 contact from a more central location to a more peripheral location on the interface.
The mutant also displays other more peripheral interactions. Fig. S2 shows that the H-bond accepted by D355sACE2 from the backbone amide of T500sRDB is significantly more populated in the mutant than in WT. Fig. S3 shows that the formation of the K353sACE2-Y501sRBD H-bond in the mutant sacrifices a more central H-bond between E37sACE2 and Y505sRBD. The mutant also sacrifices a small amount of occupancy of a central H-bond between D30sACE2 and K417sRBD. Finally, in Fig.S4, we show that the mutant acquires an intermittent peripheral H-bond between the hydroxyls on Y83sACE2 and Y489sRBD.
The general pattern of changes in H-bonding interactions between sACE2 and sRBD upon the N501YsRBD mutation seems to be reduction in more centrally located H-bonds to more peripherially located H-bonds. We will see in the following sections some large-scale conformational analysis that may provide more insight into what implications this observation may have on the motion of the complex at equilibrium. All in all, the overall occupancy of H-bonds is slightly higher in WT than in the mutant (9%), consistent with the observation that the enthalpy of binding is somewhat less favorable for the mutant system.
Entropic effects of the N501Y mutation
To understand how the N501Y mutation might entropically affect binding, we first investigated interatomic positional fluctuation correlations. Dynamic cross-correlation matrices were computed from all aggregate replica trajectories for the WT and mutant systems. Each matrix element cij for atoms i and j is computed via
| (1) |
where Δri = ri − 〈ri〉 is the instantaneous fluctuation in cartesian coordinates of atom i. Graphical representations of the WT and mutant cross-correlation matrices appear in Fig. 4. Residues corresponding to RBD and ACE2 are denoted along each axes. The positive values of cij are shown in red and the negative values are shown in blue. From this we observe that there are fewer overall correlations between sRBD and sACE2 in the mutant system than in WT. ACE2 to ACE2 correlation is also less pronounced in the mutant than in WT. From this we infer that the change in the layout of interprotein H-bonds upon mutation is associated with weaker dynamic coupling between the two proteins, while at the same time sacrificing very little enthalpy of binding. A different view of the interatomic correlations is shown in Fig. 5, where we render line segments, colored by correlation value, between atoms for which |cij| ≥ 0.4. These help to illustrate that the WT complex displays much more correlated fluctuations across the protein-protein interface than does the mutant.
Figure 4:

(A) Dynamic cross-correlation matrix of WT sRBD and sACE2. (B) Dynamic cross-correlation matrix of the N501YsRBD mutant sRBD and sACE2. Red represents correlated and blue represents anticorrelated motions.
Figure 5:

Mapping atomic correlations onto the sRBD:sACE2 complex, where atom pairs for which |cij| ≥ 0.4 are indicated with lines. Red represents correlated and blue represents anticorrelated motions. in Fig. 4. (A) WT; (B) Mutant. The subunit corresponding to ACE2 region identified by a green vertical line and RBD is identified by the orange vertical line.
Normal mode analysis (NMA) reveals that these changes in correlations reduce primarily to large scale relative motion of the two proteins, which is much more pronounced in the mutant than in WT. The lowest-frequency nontrivial normal mode is depicted in Fig. 6 in a vector-field representation. Each vector represents the direction of motion of the residues where the length indicates the vibrational amplitude. From this we see that the mutant complex displays much more large-scale flexibility, with a bending motion about the protein:protein interface. The supplementary movie showing the first non-trivial mode in each system shows that there is a hinge motion at the binding interface that shows increased motion for mutant in comparison to WT. Although qualitative, this interpretation also supports the observation that the entropy of binding of the mutant is more entropically favorable than WT. Furthermore, we have projected each trajectory onto the normal mode and measured the average displacement from the mean position. The mutant complex average displacement across three replicas is 0.61 Å with a standard deviation of 0.40 Å. The WT complex average displacement across three replicas is 0.53 Å with a standard deviation of 0.31 Å.
Figure 6:

Vector field representation of the first nontrivial normal mode in (A) WT and (B) mutant. The subunit corresponding to ACE2 region identified by a green vertical line and RBD is identified by the orange vertical line. The length of each vector represents displacement and color represents The coloring of each vector correlates to the oscillation amplitude (Increasing from blue to white to red.)
NMA argues that one entropic effect of the mutation is the population of a large-scale flexibility mode in the complex that is not populated in the WT, and the H-bonding patterns seem to suggest that the more peripheral layout of H-bonds underlies this flexibility. However, the effect of the mutation is felt across the spectrum of normal modes. Because higher-frequency modes typically correspond to more localized fluctuations, we opt to consider root mean squared fluctuations (RMSF) of residue positions. Fig. 7 shows RMSF across the entire complex for both systems, and we observed that the mutant is more flexible overall across both ACE2 and RBD. In Fig. 8 we show the RMSFs of each protein from separate apo simulations together with the protein-specific RMSFs from the complex simulations, to isolate the effects of the mutation on the internal flexibility of each protein. These differences are revealed by taking the difference of the latter with the former, yielding ΔRMSFs shown in Fig. 8(C). Here we observe generally more negative ΔRMSF for the mutant than for WT, indicating slightly more suppression of fluctuations upon binding for the mutant. Residues with negative values of ΔRMSF seem to include, as expected, interface binding residues.
Figure 7:

(A) RMSF of sACE2 and sRBD system for WT (red) and N501YsRBD mutant systems (blue).
Figure 8:

(A) RMSF of sRBD for apo WT (red) and N501YsRBD (blue) mutant systems. (B) RMSF of sRBD in complex with sACE2 (aligned on sRBD) for WT (red) and N501YsRBD (blue) systems. (C) ΔRMSF for sRBD, defined as RMSF of sRBD in complex with sACE2 minus RMSF of apo sRBD, for WT (red, mean: −0.03 Å) and N501YsRBD (blue, mean: −0.07 Å) systems. Residues that bind to sACE2 are indicated with dashed vertical lines.
The apparent greater degree of suppression of fluctuations upon binding for the mutant relative to WT seems counter to the observation that the magnitude of the entropy change of binding is lower for mutant. However, fluctuations in sRBD alone do not tell the whole story. In Fig. 9 we show impact of sRBD binding on the sACE2 RMSF. The ΔRMSF for sACE2 shows significantly more positive values for the mutant than for WT, indicating that fluctuations in sACE2 increase upon binding to mutant sRBD.
Figure 9:

(A) RMSF of sACE2 from an apo simulation. (B) RMSF of sACE2 in complex with sRBD (aligned on sACE2) for WT (red) and N501YsRBD (blue) systems. (C) ΔRMSF for sACE2, defined as RMSF of sACE2 in complex with sRBD minus RMSF of apo sACE2, for WT (red, mean: −0.06 Å) and N501YsRBD (blue, mean: 0.18 Å) systems. Residues that bind to sRBD are indicated with dashed vertical lines.
The ΔRMSF was mapped onto the crystal structure of the sRBD in Fig. 10 to better visualize where the ΔRMSF values are located on the sRBD in relation to sACE2. We see that the majority of the more negative ΔRMSF values are at the interface of sACE2-sRBD for the mutant N501YsRBD system. Note that the rest of the sRBD has more positive ΔRMSF in the mutant system, indicating that although the contact residues may be more stable, the sRBD itself gains more flexibility upon binding. The overall picture is therefore one in which mutant sRBD fluctuations are seemingly transferred to sACE2 upon binding. Fig. 10 shows structures of the complexes colored by each protein’s respective ΔRMSF, and it is easy to see that in the mutant systems, although sRBD fluctuates less upon binding near the interface, sACE2 fluctuates more throughout the protein.
Figure 10:

Cartoon representations of the sRBD:sACE2 complex, colored by ΔRMSFs, with redder colors more negative and bluer more positive, for (A) WT sRBD and (B) N501Y. Positive values correspond to increased flexibility upon binding while negative values correspond to a decrease in stability.
This is aligned with the observation that overall change in binding free energy upon mutation is favorable. The sRBD is more stable upon binding and specifically the residues at the interface of ACE2 and RBD that provide increased stability (decreased flexibility) upon binding in the mutant. The residues distal to the binding interface are actually more flexible upon binding. Although ACE2 is less flexible in WT, RBD is more flexible. This corresponds to the NMA and DCCM data that the mutant system has more fluctuations at the distal ends of each protein with a stable hinge at the ACE2:RBD interface. The distal regions do not exhibit comparable fluctuations in WT and the whole system is more rigid due to the RBD to ACE2 correlations observed via DCCM as well as the hydrogen bonds at either end of the interface that latch it together.
Conclusions
We have used all-atom MD simulations of sRBD WT and N501Y mutants, their complexes with sACE2, and sACE2 alone, to present a possible explanation for the observations that the N501Y mutation results in a less favorable enthalpy of binding, a more favorable entropy of binding, and an overall more favorable binding free energy, compared to wild-type sRBD. Our analysis began with MM/GBSA calculations confirming the enthalpic effect, which we then explained by exhaustive cataloging of inter-protein H-bonding. We argued that the general trend in the change of H-bonding is toward residue pairs that are more on the periphery of the interface for the mutant. Cross-correlation and normal mode analysis revealed that the mutant complex displays more quaternary flexibility than the WT complex, which we argue is a direct result of the more “hinge-like” quality of the peripheral H-bond network in the mutant compared to WT. Both this increased large-scale flexibility and the observation that sACE2 fluctuations increase upon binding to mutant but not for WT together provide a rationale for the more favorable entropy change upon binding for the mutant compared to the wild-type sRBD.
Our results suggest that one route toward increased protein-protein binding affinity is altering the layout of interprotein contacts in the epitope region so that large-scale vibrational modes that do not compromise binding are allowed to remain active. We speculate that this could lead to the development of binding antagonists that act to suppress this flexibility, making a protein-protein interface more fragile. Further elucidating this hypothesis could be done by some selected point mutations; for example, a K353MsACE2 mutation would disrupt the strong N501YsRBD to K353sACE2 bond in the mutant system. In addition the mutation of central residues on sACE2 such as E37KsACE2 and D30EsACE2 could enhance affinity by lengthening the binding interface. Additionally, it is interesting to note that some of the interactions identified in this work implicate residues that have emerged in the recent Omicron variants including Y505H, K417N, and G496S.33 These residues are all central interactions in the WT data presented here but could present as weaker binders to their ACE2 partners in their mutant forms. Reversing these mutations systematically back to WT could further elucidate the effect of peripheral and central interactions with a spotlight on these contemporary mutations.
Supplementary Material
Acknowledgments
Funding from the National Institutes of Health (Grant No. P01 AI150471) is gratefully acknowledged. This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number ACI-1548562. This work also used the Picotte cluster in the Drexel University Research Computing Facility. M. Gatchel was supported on a Research Experience for Undergraduates Site Project (NSF Award No. 1949718, PI: M. Soroush).
Footnotes
Supporting Information
Supporting Information includes four figures showing close-up views of residue-residue interactions and their distance distributions, for both wild-type and mutant, and movies of the lowest-order modes.
Data and Software Availability
All equilibrium MD trajectories in DCD format and their associated input PSF structure files are available for download via Mendeley Data (DOI 10.17632/t8f2d5fd4v.1). Initial conditions for all MD simulations were generated using VMD v1.9.3 and its psfgen plugin, and all trajectories were generated using NAMD v2.13; both VMD and NAMD are freely available (www.ks.uiuc.edu/Research). Residue cross-correlations and Normal Mode Analysis were generated using the freely-available package, Bio3D, following existing workflow instructions at (http://thegrantlab.org/bio3d/reference). The freely available PyMol v2 (pymol.org/2) was used for visualization of correlated residues.
References
- (1).V’kovski P; Kratzel A; Steiner S; Stalder H; Thiel V Coronavirus biology and replication: implications for SARS-CoV-2. Nat. Rev. Microbiol 2021, 19, 155–170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (2).Walls AC; Park YJ; Tortorici MA; Wall A; McGuire AT; Veesler D Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell 2020, 181, 281–292.e6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (3).Cai Y; Zhang J; Xiao T; Peng H; Sterling S; Walsh RJ; Rawson S; Rits-Volloch S; Chen B Distinct conformational states of SARS-CoV-2 spike protein. Science 2020, 1586–1592. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (4).Wang S; Guo F; Liu K; Wang H; Rao S; Yang P; Jiang C Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2. Virus Res. 2008, 136, 8–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (5).Kannan S; Shaik Syed Ali P; Sheeza A Omicron (B. 1.1. 529)—Variant of concern—Molecular profile and epidemiology: A mini review. Eur. Rev. Med. Pharmacol. Sci 2021, 25, 8019–8022. [DOI] [PubMed] [Google Scholar]
- (6).Harvey WT; Carabelli AM; Jackson B; Gupta RK; Thomson EC; Harrison EM; Ludden C; Reeve R; Rambaut A; Peacock SJ; Robertson DL SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol 2021, 19, 409–424. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (7).Prévost J; Richard J; asser R; Ding S; Fage C; Anand SP; Adam D; Vergara NG; auzin A; Benlarbi M; Gong SY; oyette G; Privé A; Moreira S; Charest H; Roger M; Mothes W; Pazgier M; Brochiero E; Boivin G; Abrams CF; Schön A; Finzi A Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2. J. Biol. Chem 2021, 297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (8).Luan B; Wang H; Huynh T Molecular mechanism of the N501Y mutation for enhanced binding between SARS-CoV-2’s spike protein and human ACE2 receptor. BioRxiv 2021, [DOI] [PMC free article] [PubMed] [Google Scholar]
- (9).Liu Y; Liu J; Plante KS; Plante JA; Xie X; Zhang X; Ku Z; An Z; Scharton D; Schindewolf C; Widen SG; Menachery VD; Shi PY; Weaver SC The N501Y spike substitution enhances SARS-CoV-2 infection and transmission. Nature 2022, 602, 294–299. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (10).Tian F; Tong B; Sun L; Shi S; Zheng B; Wang Z; Dong X; Zheng P N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2. Elife 2021, 10, 69091. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (11).Chodera JD; Mobley DL Entropy-enthalpy compensation: Role and ramifications in biomolecular ligand recognition and design. Annu. Rev. Biophys 2013, 42, 121–142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (12).Phillips JC; Braun R; Wang W; Gumbart J; Tajkhorshid E; Villa E; Chipot C; Skeel RD; Kale L; Schulten K Scalable Molecular Dynamics with NAMD. J. Comp. Chem 2005, 26, 1781–1802. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (13).Humphrey W; Dalke A; Schulten K VMD - Visual Molecular Dynamics. J. Molec. Graphics 1996, 14, 33–38. [DOI] [PubMed] [Google Scholar]
- (14).Constanciel R; Contreras R Self consistent field theory of solvent effects representation by continuum models: Introduction of desolvation contribution. Theor. Chim. Acta 1984, 65, 1–11. [Google Scholar]
- (15).Zou X; Sun Y; Kuntz ID Inclusion of solvation in ligand binding free energy calculations using the generalized-born model. J. Am. Chem. Soc 1999, 121, 8033–8043. [Google Scholar]
- (16).Massova I; Kollman PA Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding. Perspect. Drug Discovery Des 2000, 18, 113–135. [Google Scholar]
- (17).Prévost J; Tolbert WD; Medjahed H; Sherburn RT; Madani N; Zoubchenok D; Gendron-Lepage G; Gaffney AE; Grenier MC; Kirk S; Vergara N; Han C; Mann BT; Chénine AL; Ahmed A; Chaiken I; Kirchhoff F; Hahn BH; Haim H; Abrams CF; Smith AB; Sodroski J; Pazgier M; Finzi A The HIV-1 ENV GP120 inner domain shapes the PHE43 cavity and the CD4 binding site. mBio 2020, 11, 1–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (18).Ongaro A; Oselladore E; Memo M; Ribaudo G; Gianoncelli A Insight into the LFA-1/SARS-CoV-2 Orf7a complex by protein–protein docking, molecular dynamics, and MM-GBSA calculations. J. Chem. Inf. Model 2021, 61, 2780–2787. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (19).Cong Y; Feng Y; Ni H; Zhi F; Miao Y; Fang B; Zhang L; Zhang JZ Anchor-Locker Binding mechanism of the coronavirus spike protein to human ACE2: insights from computational analysis. J. Chem. Inf. Model 2021, 61, 3529–3542. [DOI] [PubMed] [Google Scholar]
- (20).Wang X; Bie L; Gao J Structural Insights into the Cofactor Role of Heparin/Heparan Sulfate in Binding between the SARS-CoV-2 Spike Protein and Host Angiotensin-Converting Enzyme II. J. Chem. Inf. Model 2022, 62, 656–667. [DOI] [PubMed] [Google Scholar]
- (21).Marimuthu P; Gorle S; Karnati KR Mechanistic Insights into SARS-CoV-2 Main Protease Inhibition Reveals Hotspot Residues. J. Chem. Inf. Model 2021, 61, 6053–6065. [DOI] [PubMed] [Google Scholar]
- (22).Zhou L; Liu T; Mo M; Shi Y; Wu L; Li Y; Qin Q; Zhu W; Wu C; Gong L; Xu Z Exploring the Binding Affinity and Mechanism between ACE2 and the Trimers of Delta and Omicron Spike Proteins by Molecular Dynamics Simulation and Bioassay. J. Chem. Inf. Model 2022, [DOI] [PubMed] [Google Scholar]
- (23).Khan A; Hussain S; Ahmad S; Suleman M; Bukhari I; Khan T; Rashid F; Azad AK; Waseem M; Khan W; Hussain Z; Khan A; Ali SS; Qin Q; Wei DQ Computational modelling of potentially emerging SARS-CoV-2 spike protein RBDs mutations with higher binding affinity towards ACE2: A structural modelling study. Comput. Biol. Med 2022, 141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (24).Han Y; Wang Z; Wei Z; Schapiro I; Li J Binding affinity and mechanisms of SARS-CoV-2 variants. Comput. Struct. Biotechnol. J 2021, 19, 4184–4191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (25).Ahmed WS; Philip AM; Biswas KH Decreased Interfacial Dynamics Caused by the N501Y Mutation in the SARS-CoV-2 S1 Spike:ACE2 Complex. Front. Mol. Biosci 2022, 9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (26).Antony P; Vijayan R Molecular dynamics simulation study of the interaction between human angiotensin converting enzyme 2 and spike protein receptor binding domain of the SARS-CoV-2 B. 1.617 variant. Biomolecules 2021, 11, 1244. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (27).Spinello A; Saltalamacchia A; Borisek J; Magistrato A Allosteric cross-talk among spike’s receptor-binding domain mutations of the SARS-CoV-2 South African variant triggers an effective hijacking of human cell receptor. J. Phys. Chem. Lett 2021, 12, 5987–5993. [DOI] [PubMed] [Google Scholar]
- (28).Williams JK; Wang B; Sam A; Hoop CL; Case DA; Baum J Molecular dynamics analysis of a flexible loop at the binding interface of the SARS-CoV-2 spike protein receptor-binding domain. Proteins: Struct., Funct., Bioinf 2022, 90, 1044–1053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (29).Glykos NM Software news and updates. Carma: a molecular dynamics analysis program. J. Comput. Chem 2006, 27, 1765–8. [DOI] [PubMed] [Google Scholar]
- (30).Carlsson J; Aqvist J Absolute and relative entropies from computer simulation with applications to ligand binding. J. Phys. Chem. B 2005, 109, 6448–56. [DOI] [PubMed] [Google Scholar]
- (31).Grant BJ; Rodrigues AP; ElSawy KM; McCammon JA; Caves LS Bio3d: an R package for the comparative analysis of protein structures. Bioinformatics 2006, 22, 2695–2696. [DOI] [PubMed] [Google Scholar]
- (32).Schrödinger, LLC,; DeLano W PyMOL. http://www.pymol.org/pymol, visited on 2022-07-18.
- (33).Tian D; Sun Y; Xu H; Ye Q The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant. J. Med. Virol 2022, 94, 2376–2383. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All equilibrium MD trajectories in DCD format and their associated input PSF structure files are available for download via Mendeley Data (DOI 10.17632/t8f2d5fd4v.1). Initial conditions for all MD simulations were generated using VMD v1.9.3 and its psfgen plugin, and all trajectories were generated using NAMD v2.13; both VMD and NAMD are freely available (www.ks.uiuc.edu/Research). Residue cross-correlations and Normal Mode Analysis were generated using the freely-available package, Bio3D, following existing workflow instructions at (http://thegrantlab.org/bio3d/reference). The freely available PyMol v2 (pymol.org/2) was used for visualization of correlated residues.
